scholarly journals Discovery of Novel Dual Inhibitors of the Wild-Type and the Most Prevalent Drug-Resistant Mutant, S31N, of the M2 Proton Channel from Influenza A Virus

2013 ◽  
Vol 56 (7) ◽  
pp. 2804-2812 ◽  
Author(s):  
Jizhou Wang ◽  
Chunlong Ma ◽  
Jun Wang ◽  
Hyunil Jo ◽  
Belgin Canturk ◽  
...  

2016 ◽  
Vol 108 ◽  
pp. 605-615 ◽  
Author(s):  
Jianghong Dong ◽  
Shengwei Chen ◽  
Runfeng Li ◽  
Wei Cui ◽  
Haiming Jiang ◽  
...  








2018 ◽  
Vol 10 (3) ◽  
pp. 211-216 ◽  
Author(s):  
Qing-Yan Guo ◽  
Long-Hua Zhang ◽  
Chao Zuo ◽  
Dong-Liang Huang ◽  
Zhipeng A. Wang ◽  
...  


2019 ◽  
Vol 221 (10) ◽  
pp. 1699-1702 ◽  
Author(s):  
Maki Kiso ◽  
Seiya Yamayoshi ◽  
Jurika Murakami ◽  
Yoshihiro Kawaoka

Abstract Background Immunocompromised patients infected with influenza virus require prolonged treatment with neuraminidase inhibitors, because these patients are not able to eradicate the virus from the respiratory tract, leading to the emergence of drug-resistant mutant viruses. Methods In this study, we examined the efficacy of baloxavir marboxil in nude mice that were immunologically deficient. Results Daily treatment with a suboptimal dose of baloxavir marboxil increased the survival time of the virus-infected nude mice but did not clear the virus from their respiratory organs, resulting in gradual body weight loss after termination of treatment. Conclusions Despite the prolonged baloxavir marboxil treatment, few resistant mutants were detected.



2015 ◽  
Vol 96 ◽  
pp. 318-329 ◽  
Author(s):  
Matias Rey-Carrizo ◽  
Sabrina Gazzarrini ◽  
Salomé Llabrés ◽  
Marta Frigolé-Vivas ◽  
Jordi Juárez-Jiménez ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document